Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response

Mariëtte I.E. van Poelgeest(Leiden University), Sjoerd H. van der Burg(Leiden University Medical Center), Toos Daemen(University Medical Center Groningen), Tjalling Bosse(Leiden University Medical Center), Marjolein J. Kagie(Medisch Centrum Haaglanden), J. Hanneke N.G. Oude Elberink(University Medical Center Groningen), Dorien M. A. Berends-van der Meer(Leiden University Medical Center), Cornelis J.M. Melief(ISA Pharmaceuticals (Netherlands)), Renee Vermeij(University Medical Center Groningen), Linda F. M. Stynenbosch(Leiden University Medical Center), A. Rob P.M. Valentijn(Leiden University Medical Center), Marc van Beurden(Oncode Institute), Margriet J. Löwik(Leiden University Medical Center), Nikki M. Loof(Leiden University Medical Center), Bart W.J. Hellebrekers(Haga Hospital), Henk W.R. Schreuder(Gynecologic Oncology Group), Hans W. Nijman(University Medical Center Groningen), Marij J.P. Welters(Leiden University Medical Center), Lorraine M. Fathers(Leiden University Medical Center), Theo Stijnen(Leiden University Medical Center), Gemma G. Kenter(European Organisation for Research and Treatment of Cancer), Edith M.G. van Esch(Leiden University Medical Center), Jaap Oostendorp(Leiden University Medical Center), J. Baptist Trimbos(Leiden University), Harry Hollema(University Medical Center Groningen), G. J. Fleuren(Leiden University), Ineke L.E. Hamming(University Medical Center Groningen)
Clinical Cancer Research
January 26, 2016
Cited by 166


Related Papers